News Focus
News Focus
Followers 30
Posts 5248
Boards Moderated 0
Alias Born 10/16/2012

Re: Protector post# 268135

Wednesday, 07/13/2016 10:54:49 AM

Wednesday, July 13, 2016 10:54:49 AM

Post# of 347009

(ref. dose switching, 1st ln NSCLC, Pancreatic randomising, SUNRISE exceptional control arm performance compared to same with Opdivo, etc).



What better reason to bring in fresh blood to the BOD who has the aptitude to navigate these trials into successful completion? But the BOD would rather insulate themselves. They have no stake in the game. No accountability. No ramifications with the failures. Shareholders carry all the risk. If Bavi works, let's move it along.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y